Regeneron Pharmaceuticals, Inc.

Advisors Capital Management, LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

285

Value ($000)

220

Weight

0.0%

2022 Q1 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	220	0.0%	285	12/31/2025
2025 Q1	5/27/2025	584	0.0%	921	3/31/2025
2024 Q4	2/13/2025	1,227	0.0%	1,722	12/31/2024
2024 Q3	11/14/2024	1,848	0.0%	1,757	9/30/2024
2024 Q2	8/9/2024	1,665	0.0%	1,583	6/30/2024
2024 Q1	5/6/2024	1,517	0.0%	1,575	3/31/2024
2023 Q4	2/14/2024	1,382	0.0%	1,573	12/31/2023
2023 Q3	11/15/2023	323	0.0%	392	9/30/2023
2023 Q2	8/3/2023	284	0.0%	395	6/30/2023
2023 Q1	5/4/2023	313	0.0%	381	3/31/2023
2022 Q4	2/13/2023	272	0.0%	377	12/31/2022
2022 Q3	11/16/2022	282	0.0%	380	9/30/2022
2022 Q2	8/12/2022	220	0.0%	373	6/30/2022
2022 Q1	5/10/2022	262	0.0%	375	3/31/2022